Novartis

Bewertungs-Analyse

🚫 Wird derzeit von keinem unserer 15 getrackten Smart Money Manager gehalten. Smart Money Tracker →

Über das Unternehmen

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of myelofibrosis, polycythemia vera, and acu

Trading-Daten

💵 Dividenden-Info

Ähnliche Aktien aus dem Sektor

Wo kann ich Novartis kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.